Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

50
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
50
Oral Hypoglycemic Agents: Sulfonylureas01:17

Oral Hypoglycemic Agents: Sulfonylureas

1.7K
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vector venom: venomics of Aedes albopictus reveals a large enzyme repertoire and novel cecropins with activity against E. coli.

npj drug discovery·2026
Same author

Ontogenetic variation in Milos viper (Macrovipera schweizeri) venom composition and biochemical activity.

Comparative biochemistry and physiology. Toxicology & pharmacology : CBP·2026
Same author

Strevertene A, a Streptomyces-Derived Macrolide, Reveals Selective Activity against the Human Parasite <i>Schistosoma mansoni</i>.

ACS omega·2026
Same author

Correction: Furin as target for suppression of mosquito-borne viruses.

Virology journal·2026
Same author

A Bifunctional Protease Cleaves the Leader Peptide in the Biosynthesis of Class I Microviridins.

Chembiochem : a European journal of chemical biology·2026
Same author

Furin as target for suppression of mosquito-borne viruses.

Virology journal·2026

Related Experiment Video

Updated: Apr 3, 2026

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

3.1K

Native Metabolomics Unveils Suomilide Analogs with Potent Trypsin Inhibitory Activity.

Amira Naimi1, Christoph Ulbricht2, Tung Lam Trinh2

  • 1Institute of Pharmaceutical Biology and Biotechnology, Marburg University, Robert-Koch-Str. 4, 35037 Marburg, Germany.

Journal of Natural Products
|April 1, 2026
PubMed
Summary

Cyanobacteria produce potent serine protease inhibitors. Researchers discovered new suomilides G and H from Nostoc sp. KVJ20, which effectively inhibit trypsin, highlighting their pharmaceutical potential.

More Related Videos

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

772
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

9.1K

Related Experiment Videos

Last Updated: Apr 3, 2026

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

3.1K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

772
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

9.1K

Area of Science:

  • Natural Product Chemistry
  • Biochemistry
  • Pharmacology

Background:

  • Cyanobacteria are prolific producers of bioactive compounds, including serine protease inhibitors.
  • These natural products represent a valuable resource for discovering novel pharmaceutical lead structures.

Purpose of the Study:

  • To employ native metabolomics for rapid screening of cyanobacterial extracts against trypsin.
  • To discover and characterize new potent serine protease inhibitors from cyanobacteria.

Main Methods:

  • Native metabolomics coupled with liquid chromatography-high resolution tandem mass spectrometry (LC-HR-MS/MS).
  • Isolation and structural elucidation using 1D/2D NMR spectroscopy and Marfey's analysis.
  • Bioinformatic investigations and competitive bioassays for enzyme inhibition.

Main Results:

  • Identification of the suomilide family from Nostoc sp. KVJ20 as potent trypsin inhibitors.
  • Discovery and structural characterization of two new suomilides, G and H, alongside known congeners B and D.
  • Demonstrated low nanomolar to high picomolar inhibitory concentrations for all four isolated suomilides against trypsin.

Conclusions:

  • Suomilides represent an exceptionally potent class of serine protease inhibitors.
  • Cyanobacteria are a rich source for novel drug leads, exemplified by the suomilide family.
  • The applied metabolomic approach enables rapid discovery of bioactive natural products.